GLAB Share Price Performance
CA$0.06
-0.57 (-90.48%)
Price CA$0.06
Share Pricen/a
Gemina Laboratories Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
GLAB Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Gemina Laboratories Ltd. Key Details
Last Reported Earnings
Oct 31, 2025
Next Reporting Earnings
n/a
- -0.038
- 100.00%
- -26,928.43%
- -4.7%
About GLAB
- Founded
- 2017
- Employees
- n/a
- CEO
- WebsiteView website
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.
